AlphAIAlphAI — Financial news for AI agents
nbr.co.nzAUG 312 min read$FPH

NZX 50 gains for 4th month as Gentrack surges out of the doldrums

New Zealand's S&P/NZX 50 index rose 1.1% on Monday, ending August with a 1.6% monthly gain. Gentrack led gains with a 31% surge after board changes, while Fisher & Paykel Healthcare rose 9.1%. Westpac Banking Corp fell 8.1%. Investors rebalanced portfolios, with Auckland Airport seeing heavy trading. Asian markets were muted, and oil prices climbed after US-Iran tensions.

Original reporting
nbr.co.nz
Published Aug 31, 2026, 9:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 9:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
NZX 50 gains for 4th month as Gentrack surges out of the doldrums — source image
Source · nbr.co.nz
Decision brief

The 30-second read

$FPHBullishLow
01

Why it matters

Overall market momentum is positive, but many moves lack concrete corporate news, limiting actionable insight.

02

Market read

Strong intra‑day moves in a few NZX constituents drive the index, but the lack of fresh corporate disclosures limits trading relevance.

03

What to watch

Potential impact of upcoming Reserve Bank rate decision and Middle East tensions on commodity‑linked stocks.

Relevance 4/10Novelty 2/10Timing: Monday

Background

The article reports a broad NZX 50 rally driven by several individual stock moves and sector rebalancing.

Company-level read

Ticker impact

$FPHBullishMedium confidence
Context

Fisher & Paykel Healthcare posted a 9.1% monthly gain, its best in two years.

Expected impact

Potential continuation if earnings beat expectations later.

Evidence & confidence

Price move is notable but lacks a specific new event beyond market momentum.

Market effects

Sector

Utility software and healthcare stocks show strength, while banking and property sectors face pressure.

Regional

NZX 50 outperforms regional peers, highlighting local momentum.

Global

Limited; primarily a regional market move with no direct global macro impact.

Counterpoint

What could challenge this read

The rally may be overextended; lack of fundamental catalysts could lead to a pullback.

Key entities

  • Company
    Gentrack Ltd

    Utilities software developer with a 31% price surge.

  • Company
    Fisher & Paykel Healthcare

    Medical device maker with a 9.1% monthly gain.

  • Company
    Auckland International Airport

    Airport operator contributing significant turnover.

Read at source← All news

Related articles

OCT 22
$FPHMed

Five Point Q3 Earnings Call Highlights

Five Point (FPH) expects small Q4 net income and $20M for 2026, adjusting land sale expectations. Q3 saw 54 homes sold at Great Park, 92 at Valencia. Cash position: $358.7M, liquidity: $576.2M. CFO Tobler forecasts >$300M cash by 2026, with $125M development spending planned. Management revenue: $13.9M, Hearthstone AUM: $3.4B. Progress reported at Valencia and Candlestick.

finance.yahoo.com2 min
OCT 22
$FPHMed

Five Point Holdings, LLC Reports Third Quarter 2026 Results

Five Point Holdings, LLC (FPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Five Point Holdings, LLC Reports Third Quarter 2026 Results Third Quarter 2026 Highlights • Great Park Venture distributions and incentive compensation payments to the Company totaled $40.4 million. • Great Park builder sales of 54 homes during the quarter. • Valenci

SEC EDGAR 8-K2 min
SEP 16
$RMDMed

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

RBC Capital Markets upgraded five ASX-listed healthcare stocks to outperform, citing positive earnings growth and attractive valuations. CSL (ASX: CSL) was highlighted for market share gains, with a $213 price target. ResMed (ASX: RMD) was noted for capital management, with a $262 target. Ramsay Healthcare (ASX: RHC) was praised for cost control, with a $68 target. Fisher & Paykel (ASX: FPH) showed strong growth, with a $52 target. Nanosonics (ASX: NAN) had mixed results but a $3.75 target.

fool.com.au2 min
AUG 21
$FPHMedAI 8/10

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

nzherald.co.nz2 min
AUG 17
$FPHMed

FPH turns down KKR bid for First Gen stake over valuation

First Philippine Holdings (FPH) rejected KKR’s non-binding bid to buy an additional 8.43% stake in First Gen and then tender for First Gen’s public float at P36/share, saying it undervalues First Gen. FPH owns 67.84% of First Gen; KKR has 19.9% economic interest. The deal would have supported a delisting. First Gen also weighs a $5B offer from BREN for EDC.

bworldonline.com5 min